100
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer

, , , , , & show all
Pages 3029-3041 | Published online: 10 Apr 2019

References

  • Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–387. doi:10.1136/gutjnl-2014-30812425320104
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
  • Lin Y, Totsuka Y, He Y, et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–242.23629646
  • Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
  • Daly JM, Fry WA, Little AG, et al. Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg. 2000;190(5):562–572, discussion 572–563.
  • Deans DA, Tan BH, Wigmore SJ, et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer. 2009;100(1):63–69. doi:10.1038/sj.bjc.660482819127266
  • Djarv T, Lagergren P. Quality of life after esophagectomy for cancer. Expert Rev Gastroenterol Hepatol. 2012;6(1):115–122. doi:10.1586/egh.11.9122149587
  • Martin L, Lagergren P. Long-term weight change after oesophageal cancer surgery. Br J Surg. 2009;96(11):1308–1314. doi:10.1002/bjs.672319847871
  • Aoyama T, Sato T, Maezawa Y, et al. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer. Int J Clin Oncol. 2017;22(3):476–483. doi:10.1007/s10147-017-1089-y28176023
  • Cespedes FEM, Kroenke CH, Bradshaw PT, et al. Postdiagnosis weight change and survival following a diagnosis of early-stage breast cancer. Cancer Epidemiol Biomarkers Prev. 2017;26(1):44–50. doi:10.1158/1055-9965.EPI-16-015027566419
  • Meyerht JA, Kroenke CH, Prado CM, et al. Association of weight change after colorectal cancer diagnosis and outcomes in the Kaiser Permanente Northern California population. Cancer Epidemiol Biomarkers Prev. 2017;26(1):30–37. doi:10.1158/1055-9965.EPI-16-014527986654
  • Hynes O, Anandavadivelan P, Gossage J, Johar AM, Lagergren J, Lagergren P. The impact of pre- and post-operative weight loss and body mass index on prognosis in patients with oesophageal cancer. Eur J Surg Oncol. 2017;43(8):1559–1565. doi:10.1016/j.ejso.2017.05.02328655483
  • van der Schaaf MK, Tilanus HW, van Lanschot JJ, et al. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection. J Thorac Cardiovasc Surg. 2014;147(1):490–495. doi:10.1016/j.jtcvs.2013.07.07224060365
  • Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706–1718. doi:10.1093/ije/dys17623148106
  • Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8(6):340–347. doi:10.1038/nrgastro.2011.7321643038
  • Zhang SS, Yang H, Luo KJ, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109(11):2894–2903. doi:10.1038/bjc.2013.66624201750
  • Li XH, Gu WS, Wang XP, et al. Low preoperative albumin-to-globulin ratio predict poor survival and negatively correlated with fibrinogen in resectable esophageal squamous cell carcinoma. J Cancer. 2017;8(10):1833–1842. doi:10.7150/jca.1906228819381
  • Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–1724. doi:10.1245/s10434-010-1024-120369299
  • Steering Committee of the Western Pacific Region of the World Health Organization TIAF. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Melbourne (Australia): Health Communications Australia Pty Limited; 2000.
  • Mal F, Perniceni T, Levard H, Denet C, Validire P, Gayet B. Pre-operative predictive factors of early recurrence after resection of adenocarcinoma of the esophagus and cardia. Gastroenterol Clin Biol. 2005;29(12):1275–1278.16518287
  • Stahl M, Wilke H, Stuschke M, et al. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. J Cancer Res Clin Oncol. 2005;131(1):67–72. doi:10.1007/s00432-004-0604-515480782
  • Cook MB, Greenwood DC, Hardie LJ, Forman D, Wild CP. On the association between body mass index and Barrett’s esophagus. Ann Thorac Surg. 2009;88(5):1728. doi:10.1016/j.athoracsur.2009.04.14219853166
  • Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133(1):34–41. quiz 311. doi:10.1053/j.gastro.2007.04.04617631128
  • Kamat P, Wen S, Morris J, Anandasabapathy S. Exploring the association between elevated body mass index and Barrett’s esophagus: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87(2):655–662. doi:10.1016/j.athoracsur.2008.08.00319161814
  • Nathanson BH, Navab F. An analysis of weight gains and body mass index in patients with Barrett’s esophagus. J Acad Nutr Diet. 2016;116(7):1156–1162. doi:10.1016/j.jand.2016.03.00927102137
  • Bell S, Kong JC, Wale R, et al. The effect of increasing body mass index on laparoscopic surgery for colon and rectal cancer. Colorectal Dis. 2018. doi:10.1111/codi.14107
  • Cho WK, Choi DH, Park W, et al. Effect of body mass index on survival in breast cancer patients according to subtype, metabolic syndrome, and treatment. Clin Breast Cancer. 2018. doi:10.1016/j.clbc.2018.04.010
  • Cong Z, Wang D, Cao Y. The relationship between body mass index changes during chemotherapy and prognosis of patients with advanced colorectal cancer: a retrospective cohort study. Medicine (Baltimore). 2018;97(22):e10843. doi:10.1097/MD.000000000001084329851794
  • Desmedt C, Demicheli R, Fornili M, et al. Potential benefit of intra-operative administration of ketorolac on breast cancer recurrence according to the patient’s body mass index. J Natl Cancer Inst. 2018. doi:10.1093/jnci/djy042
  • Fang X, Wei J, He X, et al. Quantitative association between body mass index and the risk of cancer: a global meta-analysis of prospective cohort studies. Int J Cancer. 2018. doi:10.1002/ijc.31553
  • Okura T, Fujii M, Shiode J, et al. Impact of body mass index on survival of pancreatic cancer patients in Japan. Acta Med Okayama. 2018;72(2):129–135. doi:10.18926/AMO/5585329674761
  • Wang C, Guo M, Zhang N, Wang G. Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer. World J Surg Oncol. 2018;16(1):90. doi:10.1186/s12957-018-1394-629751759
  • Zhang J, Chen Q, Li ZM, Xu XD, Song AF, Wang LS. Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis. Oncotarget. 2018;9(17):13959–13970. doi:10.18632/oncotarget.2421029568408
  • Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872–878. doi:10.1158/1055-9965.EPI-05-086016702363
  • Li SD, Mobarhan S. Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Nutr Rev. 2000;58(2 Pt 1):54–56.10748609
  • Shinkai H, Iijima K, Koike T, et al. Association between the body mass index and the risk of Barrett’s esophagus in Japan. Digestion. 2014;90(1):1–9. doi:10.1159/00035777625074386
  • Smith M, Zhou M, Whitlock G, et al. Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer. 2008;122(7):1604–1610. doi:10.1002/ijc.2319818059032
  • Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113(3):456–463. doi:10.1002/ijc.2061615455378
  • Watanabe M, Ishimoto T, Baba Y, et al. Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2013;20(12):3984–3991. doi:10.1245/s10434-013-3073-823797753
  • Trivers KF, De Roos AJ, Gammon MD, et al. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol. 2005;3(3):225–230.15765441
  • Thrift AP, Nagle CM, Fahey PP, et al. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. 2012;131(5):E759–768. doi:10.1002/ijc.2742022213172
  • Morgan TM, Tang D, Stratton KL, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011;59(6):923–928. doi:10.1016/j.eururo.2011.01.03421295907
  • Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9(1):29–35. doi:10.1054/jcaf.2003.412612870
  • Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–198. doi:10.1038/nrclinonc.2015.20026573424
  • Martin L, Lagergren J, Lindblad M, Rouvelas I, Lagergren P. Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg. 2007;94(12):1496–1500. doi:10.1002/bjs.588117668914
  • Ouattara M, D’Journo XB, Loundou A, et al. Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer. Eur J Cardiothorac Surg. 2012;41(5):1088–1093. doi:10.1093/ejcts/ezr18222334635